• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性血小板减少性紫癜的根除治疗:随机试验的荟萃分析

Eradication in Idiopathic Thrombocytopenic Purpura: A Meta-Analysis of Randomized Trials.

作者信息

Kim Bum Jun, Kim Hyeong Su, Jang Hyun Joo, Kim Jung Han

机构信息

Division of Hemato-Oncology, Department of Internal Medicine, Kangnam Sacred-Heart Hospital, Hallym University Medical Center, Hallym University College of Medicine, Seoul, Republic of Korea.

Department of Internal Medicine, National Army Capital Hospital, The Armed Forces Medical Command, Sungnam, Gyeonggi-do, Republic of Korea.

出版信息

Gastroenterol Res Pract. 2018 Oct 9;2018:6090878. doi: 10.1155/2018/6090878. eCollection 2018.

DOI:10.1155/2018/6090878
PMID:30402091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6198559/
Abstract

OBJECTIVE

Several recent reviews of published studies have shown that the eradication of infection in patients with ITP improved thrombocytopenia in about half of the cases. However, most included studies were observational case series. We performed the first meta-analysis of randomized trials to gain a better insight into the effect of eradication in ITP patients.

METHODS

A systematic computerized search of the electronic databases including PubMed, EMBASE, Google Scholar, and Cochrane Library (up to December 2017) was conducted.

RESULTS

From six studies, a total of 241 patients (125 in eradication group and 116 in control group) were included in the meta-analysis. Patients in the eradication group showed significantly higher overall platelet response rate than those in the control group (odds ratio = 1.93, 95% confidence interval: 1.01-3.71, = 0.05). In the subgroup analysis, however, children in the eradication group failed to show statistically better response rate than those in the noneradication group (odds ratio = 1.80, 95% confidence interval: 0.88-3.65, = 0.11).

CONCLUSIONS

This meta-analysis indicates that eradication has a significant therapeutic effect in patients with ITP. Considering the intrinsic limits in the design and sample size of the included studies, however, large randomized controlled trials are warranted to validate the therapeutic impact of eradication in adults as well as children with ITP.

摘要

目的

近期对已发表研究的几项综述表明,根除ITP患者的感染可使约一半病例的血小板减少症得到改善。然而,大多数纳入研究为观察性病例系列。我们进行了第一项随机试验的荟萃分析,以更好地了解根除感染对ITP患者的影响。

方法

对包括PubMed、EMBASE、谷歌学术和Cochrane图书馆(截至2017年12月)在内的电子数据库进行系统的计算机检索。

结果

六项研究共纳入241例患者(根除感染组125例,对照组116例)进行荟萃分析。根除感染组患者的总体血小板反应率显著高于对照组(优势比=1.93,95%置信区间:1.01-3.71,P=0.05)。然而,在亚组分析中,根除感染组的儿童未显示出比未根除感染组有统计学上更好的反应率(优势比=1.80,95%置信区间:0.88-3.65,P=0.11)。

结论

这项荟萃分析表明,根除感染对ITP患者有显著的治疗效果。然而,考虑到纳入研究在设计和样本量方面的固有局限性,有必要进行大型随机对照试验,以验证根除感染对成人及儿童ITP的治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d53/6198559/f02d7f7664a3/GRP2018-6090878.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d53/6198559/61ffd97b24a6/GRP2018-6090878.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d53/6198559/33a4803cd301/GRP2018-6090878.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d53/6198559/f02d7f7664a3/GRP2018-6090878.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d53/6198559/61ffd97b24a6/GRP2018-6090878.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d53/6198559/33a4803cd301/GRP2018-6090878.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d53/6198559/f02d7f7664a3/GRP2018-6090878.003.jpg

相似文献

1
Eradication in Idiopathic Thrombocytopenic Purpura: A Meta-Analysis of Randomized Trials.特发性血小板减少性紫癜的根除治疗:随机试验的荟萃分析
Gastroenterol Res Pract. 2018 Oct 9;2018:6090878. doi: 10.1155/2018/6090878. eCollection 2018.
2
Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta-analysis.幽门螺杆菌根除对特发性血小板减少性紫癜患者血小板计数的影响:一项系统评价和荟萃分析
J Antimicrob Chemother. 2007 Aug;60(2):237-46. doi: 10.1093/jac/dkm195. Epub 2007 Jun 7.
3
Effect of eradication on patients with ITP: a meta-analysis of studies conducted in the Middle East.根除治疗对免疫性血小板减少症患者的影响:中东地区开展的研究的荟萃分析
Blood Res. 2021 Mar 31;56(1):38-43. doi: 10.5045/br.2021.2020189.
4
Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan.根除疗法作为幽门螺杆菌阳性的特发性血小板减少性紫癜的一线治疗方法是否有用?对日本207例已根除幽门螺杆菌的慢性免疫性血小板减少症病例的分析。
Int J Hematol. 2005 Feb;81(2):162-8. doi: 10.1532/ijh97.04146.
5
Helicobacter pylori infection and idiopathic thrombocytopenic purpura.幽门螺杆菌感染与特发性血小板减少性紫癜
Int J Hematol. 2005 Feb;81(2):113-8. doi: 10.1532/ijh97.04161.
6
Helicobacter pylori and immune thrombocytopenic purpura: unsolved questions and controversies.幽门螺杆菌与免疫性血小板减少性紫癜:未解决的问题与争议
Int J Hematol. 2006 Nov;84(4):309-15. doi: 10.1532/IJH97.06188.
7
Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in idiopathic thrombocytopenic purpura? Our experience and a literature review.幽门螺杆菌根除治疗真的能改善特发性血小板减少性紫癜的血小板减少情况吗?我们的经验及文献综述
Int J Hematol. 2003 Apr;77(3):239-44. doi: 10.1007/BF02983780.
8
Long-term efficacy of Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura: 7-year follow-up prospective study.幽门螺杆菌根除治疗特发性血小板减少性紫癜患者的长期疗效:7年随访前瞻性研究
Ann Hematol. 2009 Aug;88(8):789-93. doi: 10.1007/s00277-008-0667-5. Epub 2008 Dec 19.
9
Platelet activation in Helicobacter pylori-associated idiopathic thrombocytopenic purpura: eradication reduces platelet activation but seldom improves platelet counts.幽门螺杆菌相关性特发性血小板减少性紫癜中的血小板活化:根除治疗可降低血小板活化,但很少能改善血小板计数。
Acta Haematol. 2006;116(1):19-24. doi: 10.1159/000092343.
10
Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature.幽门螺杆菌根除:免疫性血小板减少性紫癜的新疗法?文献综述
Am J Hematol. 2005 Feb;78(2):142-50. doi: 10.1002/ajh.20250.

引用本文的文献

1
Antimicrobial Resistance and the Role of Next-Generation Sequencing.抗菌药物耐药性与新一代测序技术的作用
Gastroenterol Hepatol (N Y). 2024 Aug;20(8):469-476.
2
Machine Learning-Driven Classification of Urease Inhibitors Leveraging Physicochemical Properties as Effective Filter Criteria.基于物理化学性质作为有效筛选标准的机器学习驱动的脲酶抑制剂分类
Int J Mol Sci. 2024 Apr 13;25(8):4303. doi: 10.3390/ijms25084303.
3
[Not Available].[无可用内容]。

本文引用的文献

1
Effect of Helicobacter pylori Eradication on Long-Term Survival after Distal Gastrectomy for Gastric Cancer.幽门螺杆菌根除对胃癌远端胃切除术后长期生存的影响。
Cancer Res Treat. 2016 Jul;48(3):1020-9. doi: 10.4143/crt.2015.264. Epub 2015 Nov 17.
2
Presentation of meta-analysis plots.Meta分析图的展示。
J Med Screen. 2015 Mar;22(1):49-51. doi: 10.1177/0969141314556490.
3
Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography.免疫性血小板减少性紫癜患者幽门螺杆菌根除治疗:综述及生物地理学的作用
Tunis Med. 2023 Aug-Sep;101(8-9):657-669.
4
Efficacy of a 2-week therapy with levofloxacin concomitant versus a levofloxacin sequential regimen for Helicobacter pylori infection in the Syrian population: a study protocol for randomized controlled trial.左氧氟沙星两周联合疗法与序贯疗法治疗叙利亚人群幽门螺杆菌感染的疗效:一项随机对照试验研究方案。
Trials. 2024 Jan 15;25(1):55. doi: 10.1186/s13063-024-07906-3.
5
Impact of Infection upon the Evolution and Outcome of Pediatric Immune Thrombocytopenic Purpura: A Comprehensive Review.感染对儿童免疫性血小板减少性紫癜的演变及结局的影响:一项综述
Diagnostics (Basel). 2023 Oct 13;13(20):3205. doi: 10.3390/diagnostics13203205.
6
Infections in Children.儿童感染
Antibiotics (Basel). 2023 Sep 12;12(9):1440. doi: 10.3390/antibiotics12091440.
7
Successful treatment of coexisting membranous nephropathy and immune thrombocytopenia by eradicating gastric Helicobacter pylori infection: a case report.成功治疗并存的膜性肾病和免疫性血小板减少症根除胃幽门螺杆菌感染:一例报告。
CEN Case Rep. 2024 Apr;13(2):98-103. doi: 10.1007/s13730-023-00805-7. Epub 2023 Jul 8.
8
Helicobacter pylori infection.幽门螺杆菌感染。
Nat Rev Dis Primers. 2023 Apr 20;9(1):19. doi: 10.1038/s41572-023-00431-8.
9
Vietnam Association of Gastroenterology (VNAGE) consensus on the management of infection.越南胃肠病学协会(VNAGE)关于感染管理的共识
Front Med (Lausanne). 2023 Jan 12;9:1065045. doi: 10.3389/fmed.2022.1065045. eCollection 2022.
10
Helicobacter pylori infection: is there circulating vacuolating cytotoxin A or cytotoxin-associated gene A protein?幽门螺杆菌感染:是否存在循环空泡毒素A或细胞毒素相关基因A蛋白?
Gut Pathog. 2022 Dec 3;14(1):43. doi: 10.1186/s13099-022-00519-8.
Helicobacter. 2015 Aug;20(4):239-51. doi: 10.1111/hel.12200. Epub 2015 Mar 1.
4
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia.幽门螺杆菌根除治疗对中度血小板减少的免疫性血小板减少症患者一线治疗的疗效。
Ann Hematol. 2015 May;94(5):739-46. doi: 10.1007/s00277-014-2268-9. Epub 2014 Dec 13.
5
Helicobacter pylori infection & immune thrombocytopenic purpura in children and adolescents: A randomized controlled trial.儿童和青少年幽门螺杆菌感染与免疫性血小板减少性紫癜:一项随机对照试验。
Platelets. 2015;26(4):336-41. doi: 10.3109/09537104.2014.911836. Epub 2014 May 15.
6
Helicobacter pylori-associated immune thrombocytopenia: clinical features and pathogenic mechanisms.幽门螺杆菌相关免疫性血小板减少症:临床特征与致病机制
World J Gastroenterol. 2014 Jan 21;20(3):714-23. doi: 10.3748/wjg.v20.i3.714.
7
Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses.评价发表的系统评价和荟萃分析的质量对首选报告项目的系统评价和荟萃分析 (PRISMA) 声明的认可。
PLoS One. 2013 Dec 26;8(12):e83138. doi: 10.1371/journal.pone.0083138. eCollection 2013.
8
Current management of immune thrombocytopenia.免疫性血小板减少症的当前管理
Hematology Am Soc Hematol Educ Program. 2013;2013:276-82. doi: 10.1182/asheducation-2013.1.276.
9
VacA, the vacuolating cytotoxin of Helicobacter pylori, binds to multimerin 1 on human platelets.幽门螺杆菌空泡毒素 VacA 与人血小板上的多聚蛋白 1 结合。
Thromb J. 2013 Nov 12;11(1):23. doi: 10.1186/1477-9560-11-23.
10
[Clinical significance of Helicobacter pylori in children with idiopathic thrombocytopenic purpura].[幽门螺杆菌在儿童特发性血小板减少性紫癜中的临床意义]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Apr;21(2):419-21. doi: 10.7534/j.issn.1009-2137.2013.02.033.